Feature Precipio aims to prevent misdiagnosis of blood-related cancers Using a combination of advanced lab technologies, and a platform giving access to expert academic pathologists, Precipio (NASDAQ:PRPO) has staked out a unique position in its battle to prevent misdiagnosis of blood... August 27, 2019